The 13th edition of BioAsia 2016, kick started on February 8 at Hyderabad International Convention Centre (HICC), with the government, industry and investors converging on one platform. With proactive measures of the state and central governments, the event has instilled the much needed confidence among the industry leaders and investors have already announced their intention to invest near about Rs.1.000 crore into the pharma and biotechnology industry in Telagnana.
In fact BioAsia is Asia’s largest biotechnology and life-sciences forum that is being held annually at HICC. The 13th edition of BioAsia with the theme connecting the dots-leveraging India to succeed globally, is expected to witness participation of delegates from healthcare, biotech, pharma, life-sciences, IT, academia and startups for the next two days. BioAsia 2016 was inaugurated by Jupally Krishna Rao, minister for industries government of Telangana.
The inaugural ceremony of BioAsia 2016 witnessed many strategic partnerships and investment announcements of close to Rs.700 crore. The Telangana government further announced 13 land approvals for biotech and pharmaceutical companies.
Unveiling the 3D walk-through of the proposed Pharmacity, addressing on the occasion, Jupally Krishna Rao, said “The year not only marks the 13th edition of BioAsia but has also achieved a benchmark of excellence. It is my pleasure to note that the platform has made tremendous progress in terms of international partnerships, participation from all sectors of the industry, collaboration with firms of high repute, facilitating several meaningful business interactions and being a catalyst in forming strategic agreements between global and Indian biotech industry. I hope the interactions will result into many more partnerships and fruitful industry collaborations this year.”
The industries minister gave away the Genome Valley Excellence Awards 2016 to Nobel Laureate Prof Ada Yonath, Weismann Institute, Israel. Commenting on the occasion, Shakthi Nagappan, CEO, BioAsia said, “We have excellent participation from all industry stakeholders resulting into the expected attendance of delegates from more than 50 countries for the three day event. I am also pleased to have the participation of Norway as our Principal Country partner, Spain and South Africa as Associate Country partners.”
The inaugural ceremony saw participation from a 10 member delegation including regulatory body representatives, industry captains, high profile speakers, etc from Norway, Spain, South Africa, Srilanka, Israel and many more. Day two of BioAsia will host sessions and panel discussions on building a strategy for India - ways to develop bioeconomy, biosimilars - Make in India for global market, - Innovative strategies in the drug discovery etc conducted by eminent industry speakers. Day two of the conference will also host a CEO conclave on the theme Make in India.